FQJ-29943-08698
4 vaccinations
15 coded responses
51 check-ins
14 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 018 / MA
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Good · Site: PainFree text: Harder to concentrate at timesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Difficulty concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Survey response — day 0, dose 2MedDRA: Dizziness, Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Dizziness, hard to focusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-05-28
Survey response — day 28, dose 2MedDRA: Menstruation delayed — Feeling: GoodFree text: Late periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-06-11
-
2021-07-30
Survey response — 3 months, dose 2MedDRA: Asthma, Chest discomfort, Cough, Pre-existing disease, Wheezing — Feeling: GoodFree text: Asthma flare-ups (chest tightness, wheezing, coughing)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-29
Survey response — 6 months, dose 2MedDRA: Anxiety, Depression — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Anxiety and depressionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-02
-
2021-11-12
Dose 3 — Pfizer-BioNTech
- 2021-11-12
-
2021-11-13
Survey response — days 1–6 daily, dose 3MedDRA: Asthma, Dyspnoea, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Shortness of breath (asthma exacerbations)MedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Headache, Photophobia, Vision blurred — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: dizzyness and periods of blurred vision; light sensitivity with headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
-
2021-12-03
Survey response — day 21, dose 3MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
- 2022-05-13
-
2022-10-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-07
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-08
Survey response — days 1–6 daily, dose 4MedDRA: Balance disorder, Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Dizzy, wobblyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-10-10
- 2022-10-11
- 2022-10-13
- 2022-10-14
-
2022-10-21
Survey response — day 14, dose 4MedDRA: Chest discomfort, Dyspnoea, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Chest tightness, fatigue, shortness of breath (relapse of symptoms from health issues last few months)MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Survey response — day 21, dose 4MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Survey response — day 28, dose 4MedDRA: Asthma, Cough, Respiratory tract congestion — Feeling: GoodFree text: Coughing and chest congestion (likely asthma)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Survey response — day 35, dose 4MedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Cough, chest congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2023-01-06
-
2023-04-07
Survey response — 6 months, dose 4MedDRA: Bronchitis, Candida infection, Medical counselling, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-11
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Harder to concentrate at times
Systemic reaction (other): Difficulty concentrating
Release 8 — day 0, dose 2
Systemic reaction (other): Dizziness, hard to focus
Release 8 — day 28, dose 2
Symptoms: Late period
Release 9 — 3 months, dose 2
Symptoms: Asthma flare-ups (chest tightness, wheezing, coughing)
Release 10 — 6 months, dose 2
Symptoms: Anxiety and depression
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Shortness of breath (asthma exacerbations)
Systemic reaction (other): dizzyness and periods of blurred vision; light sensitivity with headache
Release 10 — day 21, dose 3
Symptoms: Headache
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Dizzy, wobbly
Release 12 — day 14, dose 4
Symptoms: Chest tightness, fatigue, shortness of breath (relapse of symptoms from health issues last few months)
Release 12 — day 21, dose 4
Symptoms: Headache
Release 12 — day 28, dose 4
Symptoms: Coughing and chest congestion (likely asthma)
Release 12 — day 35, dose 4
Symptoms: Cough, chest congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Asthma | ✓ | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Candida infection | · | · | ✓ |
| SD | Chest discomfort | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Wheezing | ✓ | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Balance disorder | · | · | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Photophobia | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release